BioSpace News Archive

Business

Aligos Therapeutics to Announce Third Quarter Results November 2, 2022

Aligos Therapeutics, Inc. (Nasdaq: ALGS, the “Company”) today announced that it will report the company’s third quarter 2022 financial results on Wednesday, November 2, 2022 after the close of the U.S. financial markets.

October 19, 2022
·
2 min read
Biotech Bay

Tricida Announces $125 Million Debt Facility with Hercules Capital

Tricida, Inc. announced that it has entered into a debt facility with Hercules Capital, Inc., a leader in customizing debt financing for companies in the life sciences and technology-related markets.

October 19, 2022
·
4 min read
Business

Globus Medical Schedules Third Quarter Earnings 2022 Release and Conference Call

Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2022 after the market close on Tuesday, November 8, 2022.

October 19, 2022
·
3 min read
Business

Telix Reports Third Quarter 2022 Financial Results

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 September 2022 (Q3 2022).

October 19, 2022
·
17 min read
Biotech Bay

Bristol Myers Squibb Presents Data from CheckMate -76K Showing Opdivo (nivolumab) Reduced the Risk of Recurrence or Death by 58% Versus Placebo in Patients with Completely Resected Stage IIB or IIC Melanoma

Bristol Myers Squibb announced results from the Phase 3 CheckMate -76K trial, in which Opdivo as an adjuvant therapy demonstrated a statistically significant and clinically meaningful benefit in recurrence-free survival versus placebo in patients with completely resected stage IIB or IIC melanoma.

October 19, 2022
·
43 min read
Pharm Country

Journal of Clinical Oncology Publishes Positive Results on Large-scale Implementation of Canopy’s ePRO-Based Monitoring Platform

Canopy, the first Intelligent Care Platform for oncology, today announced results from a seventeen-month, real-world study of their ePRO-based patient monitoring platform.

October 19, 2022
·
4 min read
Biotech Bay

PacBio and Twist Bioscience Deliver Initial Portfolio of Target Enrichment Panels for HiFi Sequencing

PacBio (NASDAQ: PACB) and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of an initial portfolio of off-the-shelf long-read gene panels.

October 19, 2022
·
8 min read
Deals

Ginkgo Bioworks Completes Acquisition of Zymergen

Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has completed its previously announced acquisition of Zymergen.

October 19, 2022
·
4 min read
Drug Development

IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA

IBSA Group and Granata Bio today announced the screening of the first patient in the pivotal phase III PROGRESS (PROGesterone fRozen Euploid blaStocyst tranSfer) clinical trial (Clinical Trials.gov Identifier: NCT04549116).

October 19, 2022
·
2 min read
Business

dentalcorp Announces Release Date for Third Quarter 2022 Results

dentalcorp Holdings Ltd. announced today that it will release its third quarter 2022 financial results before market open on November 9, 2022.

October 19, 2022
·
1 min read